Circadian Rhythms in Anticancer Immunity: Mechanisms and Treatment Opportunities

被引:7
作者
Pick, Robert [1 ]
Wang, Chen [1 ]
Zeng, Qun [1 ]
Gul, Zeynep Melis [1 ]
Scheiermann, Christoph [1 ,2 ,3 ,4 ]
机构
[1] Univ Geneva, Dept Pathol & Immunol, Fac Med, Geneva, Switzerland
[2] Geneva Ctr Inflammat Res GCIR, Geneva, Switzerland
[3] Translat Res Ctr Oncohaematol CRTOH, Geneva, Switzerland
[4] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Physiol & Pathophysiol, Biomed Ctr, Walter Brendel Ctr Expt Med,Fac Med, Planegg Martinsried, Germany
基金
瑞士国家科学基金会; 欧洲研究理事会;
关键词
circadian rhythms; immune system; cancer; immunotherapy; chrono-immunotherapy; REV-ERB-ALPHA; METASTATIC COLORECTAL-CANCER; CELL LUNG-CANCER; CLOCK PROTEINS; TIME; CHEMOTHERAPY; TRIAL; CHRONOTHERAPY; HOMEOSTASIS; COMPONENT;
D O I
10.1146/annurev-immunol-090122-050842
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Circadian rhythms of approximately 24 h have emerged as important modulators of the immune system. These oscillations are important for mounting short-term, innate immune responses, but surprisingly also long-term, adaptive immune responses. Recent data indicate that they play a central role in antitumor immunity, in both mice and humans. In this review, we discuss the evolving literature on circadian antitumor immune responses and the underlying mechanisms that control them. We further provide an overview of circadian treatment regimens-chrono-immunotherapies-that harness time-of-day differences in immunity for optimal efficacy. Our aim is to provide an overview for researchers and clinicians alike, for a better understanding of the circadian immune system and how to best harness it for chronotherapeutic interventions. This knowledge is important for a better understanding of immune responses per se and could revolutionize the way we approach the treatment of cancer and a range of other diseases, ultimately improving clinical practice.
引用
收藏
页码:83 / 102
页数:20
相关论文
共 107 条
[51]   X-ray structure of the hRORα LBD at 1.63 Å:: Structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORα [J].
Kallen, JA ;
Schlaeppi, JM ;
Bitsch, F ;
Geisse, S ;
Geiser, M ;
Delhon, I ;
Fournier, B .
STRUCTURE, 2002, 10 (12) :1697-1707
[52]   Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: Results from a Pilot Study in Patients with Metastatic Non-Small-Cell Lung Cancer [J].
Karaboue, Abdoulaye ;
Collon, Thierry ;
Pavese, Ida ;
Bodiguel, Viviane ;
Cucherousset, Joel ;
Zakine, Elda ;
Innominato, Pasquale F. ;
Bouchahda, Mohamed ;
Adam, Rene ;
Levi, Francis .
CANCERS, 2022, 14 (04)
[53]  
Kavakli Ibrahim Halil, 2002, Mol Interv, V2, P484, DOI 10.1124/mi.2.8.484
[54]   Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis [J].
Kettner, Nicole M. ;
Voicu, Horatio ;
Finegold, Milton J. ;
Coarfa, Cristian ;
Sreekumar, Arun ;
Putluri, Nagireddy ;
Katchy, Chinenye A. ;
Lee, Choogon ;
Moore, David D. ;
Fu, Loning .
CANCER CELL, 2016, 30 (06) :909-924
[55]  
KNYSZYNSKI A, 1981, J IMMUNOL, V127, P2508
[56]   Circadian Clocks in the Immune System [J].
Labrecque, Nathalie ;
Cermakian, Nicolas .
JOURNAL OF BIOLOGICAL RHYTHMS, 2015, 30 (04) :277-290
[57]   Adrenergic Signaling in Circadian Control of Immunity [J].
Leach, Sarah ;
Suzuki, Kazuhiro .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[58]  
Lee Y, 2021, EXP MOL MED, V53, P1529
[59]   Time-of-day specificity of anticancer drugs may be mediated by circadian regulation of the cell cycle [J].
Lee, Yool ;
Fong, Shi Yi ;
Shon, Joy ;
Zhang, Shirley L. ;
Brooks, Rebekah ;
Lahens, Nicholas F. ;
Chen, Dechun ;
Van Dang, Chi ;
Field, Jeffrey M. ;
Sehgal, Amita .
SCIENCE ADVANCES, 2021, 7 (07)
[60]   Circadian chronotherapy for human cancers [J].
Levi, Francis .
LANCET ONCOLOGY, 2001, 2 (05) :307-315